Status:
UNKNOWN
Use of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in the Diagnosis of Pleural Effusion
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Pleural Effusion
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this trial is to evaluate the level of TREM-1 in different kinds of pleural effusion.
Detailed Description
The triggering receptor expressed on myeloid cells-1 (TREM-1) is a member of the immunoglobulin superfamily, and its expression is upregulated on phagocytic cells in the presence of bacteria or fungi....
Eligibility Criteria
Inclusion
- Clinical diagnosis of pleural effusion
- Pleural effusion proved by chest sonography
Exclusion
- Conditions for which thoracentesis are contraindicated
- Pregnancy
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00166894
Start Date
May 1 2005
Last Update
November 24 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan